The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial—A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin.
 
Jose Alejandro Perez-Fidalgo
Speakers' Bureau - AstraZeneca Spain; Ipsen; Novartis; Pfizer; PharmaMar; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Uriel Bohn
No Relationships to Disclose
 
Elisa Calvo
No Relationships to Disclose
 
Yolanda Garcia Garcia
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
 
Eva Mª Guerra
No Relationships to Disclose
 
Maria Iglesias
No Relationships to Disclose
 
Luis Manso
No Relationships to Disclose
 
Ana Santaballa
No Relationships to Disclose
 
Antonio González-Martín
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro